CDC recommends Novavax’s COVID-19 vaccine to be used as primary series option for adolescents
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision letter recommending that Novavax’s COVID-19 vaccination be utilised as a secondary series option for adolescents aged 12 to 17. This advice follows the FDA’s approval of t...
2 September, 2022
Read more